China Pharma Holdings Inc.

0.8838-0.0471-5.06%Vol 682.10K1Y Perf 119.09%
Apr 9th, 2021 15:59 DELAYED
BID0.8800 ASK0.8874
Open0.9300 Previous Close0.9309
Pre-Market- After-Market0.87
 - -  -0.01 -1.57%
Target Price
- 
Analyst Rating
— 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     38.53
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     23.87
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap40.28M 
Earnings Rating
Buy
Price Range Ratio 52W %
43.04 
Earnings Date
21st May 2021

Today's Price Range

0.85320.9300

52W Range

0.32001.63

5 Year PE Ratio Range

-0.9000-1.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-5.83%
1 Month
-1.80%
3 Months
66.75%
6 Months
129.02%
1 Year
119.09%
3 Years
215.64%
5 Years
365.16%
10 Years
-64.79%

TickerPriceChg.Chg.%
CPHI0.8838-0.0471-5.06
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
0.10
0.50
0.10
0.93
-8.70
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
18.00
-23.70
1.00
-104.20
-23.95
RevenueValueIndustryS&P 500US Markets
9.10M
0.20
-7.52
-10.13
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.02-
Q02 2020-0.00-
Q01 2020--0.02-
Q04 2019--0.43-
Q03 2019--0.02-
Q02 2019--0.02-
Q01 2019--0.01-
Q04 2018--0.17-
Earnings Per EndEstimateRevision %Trend
3/2012 QR---
6/2012 QR---
12/2012 FY---
12/2013 FY---
Next Report Date21st May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume682.10K
Shares Outstanding45.58M
Trades Count1.42K
Dollar Volume679.48K
Avg. Volume3.08M
Avg. Weekly Volume1.20M
Avg. Monthly Volume5.00M
Avg. Quarterly Volume3.19M

China Pharma Holdings Inc. (AMEX: CPHI) stock closed at 0.88 per share at the end of the most recent trading day (a -5.06% change compared to the prior day closing price) with a volume of 708.40K shares and market capitalization of 40.28M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 242 people. China Pharma Holdings Inc. CEO is Zhilin Li.

The one-year performance of China Pharma Holdings Inc. stock is 119.09%, while year-to-date (YTD) performance is 96.4%. CPHI stock has a five-year performance of 365.16%. Its 52-week range is between 0.32 and 1.63, which gives CPHI stock a 52-week price range ratio of 43.04%

China Pharma Holdings Inc. currently has a PE ratio of -13.50, a price-to-book (PB) ratio of 4.78, a price-to-sale (PS) ratio of 4.96, a price to cashflow ratio of 58.60, a PEG ratio of 2.32, a ROA of -12.65%, a ROC of -89.27% and a ROE of -31.74%. The company’s profit margin is -23.95%, its EBITDA margin is 1.00%, and its revenue ttm is $9.10 Million , which makes it $0.20 revenue per share.

Of the last four earnings reports from China Pharma Holdings Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Pharma Holdings Inc.’s next earnings report date is 21st May 2021.

The consensus rating of Wall Street analysts for China Pharma Holdings Inc. is (0), with a target price of $, which is 0.00% compared to the current price. The earnings rating for China Pharma Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

China Pharma Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

China Pharma Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 33.27, ATR14 : 0.12, CCI20 : -73.83, Chaikin Money Flow : 0.30, MACD : 0.00, Money Flow Index : 16.46, ROC : -12.65, RSI : 49.43, STOCH (14,3) : 35.06, STOCH RSI : 0.66, UO : 45.91, Williams %R : -64.94), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of China Pharma Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablet, clarithromycin granule, roxithromycin dispersible tablet, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

CEO: Zhilin Li

Telephone: +86 89866811730

Address: Second Floor, No. 17, Jinpan Road, Haikou 570216, , CN

Number of employees: 242

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

News

Stocktwits